Your session is about to expire
← Back to Search
AZD2014 + Fulvestrant for Breast Cancer
Study Summary
This trial is testing a new drug, AZD2014, to see if it is safe to take with Fulvestrant, and how well it is tolerated.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 18 Patients • NCT02831257Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have at least one cancer lesion that can be measured by scans.My breast cancer is ER+ and can be treated with fulvestrant.I haven't had cancer treatments, except for palliative radiotherapy, in the last 14 days.I have not had major surgery in the last 4 weeks or minor surgery in the last 2 weeks.I have type 1 diabetes or my type 2 diabetes is not well-controlled (HbA1c > 8%).I am fully active or can carry out light work.I do not have severe heart or lung conditions.I am 18 years old or older.
- Group 1: AZD2014 with Fulvestrant
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Might I be eligible to partake in this experimental research?
"Eligible candidates who would like to participate in this medical trial must have breast cancer and be within the ages of 18 and 100. The clinical study is currently recruiting up to 99 patients."
What primary maladies is AZD2014 employed to address?
"AZD2014, a commonly used endocrine therapy, is also beneficial when treating diseases such as breast cancer and the pik3ca gene mutation."
Have there been other experiments with AZD2014 in the past?
"The AZD2014 drug was first studied 16 years ago at Lowell General Hospital. At present, there are 96 accomplished clinical trials and 140 in progress, many of which originate from Sarasota, Florida."
Is it currently possible to enroll in this medical trial?
"As per the records on clinicaltrials.gov, this experiment is closed to new participants. Although initially posted in May 2012 and last edited October 2022, at present it does not need any additional candidates; however, there are 2427 other investigations currently open for recruitment."
How many participants are being included in this experiment?
"Unfortunately, this trial is not taking participants currently. Initially appearing on the 5/8/2012 and lastly updated on 10/24/2022, if you are seeking alternate clinical trials, 2287 studies concerning breast cancer research are actively recruiting patients while 140 different investigations involving AZD2014 recruitment require test subjects."
Has the Food and Drug Administration given their stamp of approval for AZD2014?
"The safety of AZD2014 was assessed by our team at Power and found to be a 1 on the scale due to its current status as a Phase 1 trial, which indicates limited efficacy and safety data."
Is the age cutoff for this clinical experiment restricted to those under 25?
"This clinical trial only accepts patients between 18 and 100 years of age. However, there are additional 67 studies for minors aged under 18 as well as 2343 trials available to seniors over 65."
Are several healthcare facilities conducting this experiment in the local area?
"At this moment, 5 clinical trial centres are running the study. These sites can be located in Sarasota, Detroit and Oklahoma City as well as a further five areas. To reduce travel stress when taking part in the trial it is best to select your closest location."
Share this study with friends
Copy Link
Messenger